Skip to main content

Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890



Medicines Adaptive Pathways to Patients: Why, when and how to engage?

Author(s): Hans-Georg Eichler, Nicola Bedlington, Mathieu Boudes, Jacoline C. Bouvy, André W. Broekmans, Francesca Cerreta, Stuart D. Faulkner, Sue Forda, Angelika Joos, Yann Le Cam, Mark Mayer, Vinciane Pirard, Solange Corriol-Rohou
Published in: Clinical Pharmacology & Therapeutics, 2018, ISSN 0009-9236
DOI: 10.1002/cpt.1121

Managed Entry Agreements for Pharmaceuticals in the Context of Adaptive Pathways in Europe

Author(s): Jacoline C. Bouvy, Claudine Sapede, Sarah Garner
Published in: Frontiers in Pharmacology, Issue 9, 2018, ISSN 1663-9812
DOI: 10.3389/fphar.2018.00280

The evolution of adaptiveness: balancing speed and evidence

Author(s): Hans-Georg Eichler, Richard Barker, Nicola Bedlington, Jacoline C. Bouvy, André W. Broekmans, Anna Bucsics, Francesca Cerreta, Solange Corriol-Rohou, Alicia Granados, Yann Le Cam, Ad Schuurman
Published in: Nature Reviews Drug Discovery, 2018, ISSN 1474-1776
DOI: 10.1038/nrd.2018.90

Patient Access in the Context of Adaptive Pathways for Medicines: What Could Make It Work?

Author(s): C. Sapede
Published in: Value and Outcomes Spotlight, 2017, Page(s) 11-13